Combined Single-cell Dispensing and 3D Full Well Imaging for Cell Lines with >99.99% Probability of Monoclonality

Discover how UP.SIGHT ensures >99.99% monoclonality in cell line development through innovative imaging techniques, enhancing efficiency and accuracy in cloning workflows.

About the App Note

Ensuring monoclonality in cell line development is essential yet challenging. In this study, the UP.SIGHT combines double verification of single-cell dispensing, via nozzle imaging and novel 3D full-well imaging, to confirm monoclonality (>99.99%) without centrifugation or fluorescent labeling. Compatible with 96-, 384-, and 1536-well plates, the UP.SIGHT enables high-throughput single-cell cloning and colony tracking, with minimal hands-on time and increased efficiency.

Our findings support the UP.SIGHT as an all-in-one solution for rapid, accurate, and verifiable single-cell cloning workflows.

Learn more about how:

  • The UP.SIGHT provides dual assurance of monoclonality with nozzle and 3D full-well imaging
  • Imaging the full liquid volume eliminates the need for centrifugation and prevents ghost well artifacts
  • Compatibility with multiple plate formats enables high-throughput cloning and colony tracking

More Applications

Get notified on new marketing insights

Be the first to know about new B2B SaaS Marketing insights to build or refine your marketing function with the tools and knowledge of today’s industry.